Advisory panel recommends everolimus tablets for approval Cardiology Today The Cardiovascular and Renal Drugs Advisory Committee voted 11 to 1 in favor of recommending the approval of orally-administered everolimus tablets for ... Advisory Panel Recommends Novartis' Everolimus |
